Clinical Trials Sponsored by Yasuhiro Oki
Total 138 results
-
OSI PharmaceuticalsCompletedLocally Advanced or Metastatic Adenoca of the Biliary TractUnited States, Belgium, Germany, Poland, Romania, Switzerland
-
Chikara TashiroCompletedInflammatory Bowel Disease | Pancreas Disease | Hepatobiliary DiseaseJapan
-
OSI PharmaceuticalsCompletedAdvanced Solid TumorsUnited States
-
OSI PharmaceuticalsCompletedLocally Recurrent or Metastatic Cancer of the Head and Neck | Must Have Failed First-Line TherapyUnited States
-
OSI PharmaceuticalsCompletedGastric Adenocarcinoma | Gastroesophageal AdenocarcinomaUnited States, United Kingdom, Belgium
-
OBI Pharma, IncRecruiting
-
OBI Pharma, IncTerminatedPancreatic Adenocarcinoma | Solid TumorUnited States
-
Oui Therapeutics, LLCCompletedSuicidal Ideation | Suicide, AttemptedUnited States
-
OBI Pharma, IncTerminatedLocally Advanced Solid TumorUnited States
-
OBI Pharma, IncCompletedMetastatic Breast CancerUnited States, Taiwan, Korea, Republic of, China, India
-
OBI Pharma, IncRecruitingTriple Negative Breast CancerChina, Taiwan, United States, Korea, Republic of, Australia, Brazil, Hong Kong, Mexico, Russian Federation, South Africa, Ukraine, Peru, Poland
-
OBI Pharma, IncTerminatedLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States, Taiwan
-
OBI Pharma, IncCompletedMetastatic Colorectal Cancer | Metastatic Lung Cancer | Metastatic Breast Cancer | Metastatic Gastric CancerTaiwan
-
Masahiro MorikawaWhite Cross Nursing HomeCompletedInfluenza InfectionJapan
-
Mayo ClinicOSI PharmaceuticalsCompleted
-
Emory UniversityOSI PharmaceuticalsTerminatedLiver CancerUnited States
-
Ori Diagnostic Instruments LLCSuspendedBody Composition | Energy Expenditure | Energy Metabolism | Body FluidsUnited States
-
Indiana UniversityOSI PharmaceuticalsCompletedLeukemia, Myelomonocytic, AcuteUnited States
-
Northwestern UniversityOSI PharmaceuticalsWithdrawn
-
Emory UniversityOSI PharmaceuticalsWithdrawnNeoplasms | Cancer | TumorsUnited States
-
Hartford HospitalOui Therapeutics, LLCNot yet recruitingSuicidal and Self-injurious BehaviorUnited States
-
RWTH Aachen UniversityOBI MedicalRecruiting
-
University of ArkansasOSI PharmaceuticalsTerminated
-
OSI PharmaceuticalsTerminatedRecurrent or Refractory Pediatric EpendymomaUnited States, Canada, United Kingdom
-
OSI PharmaceuticalsTerminatedEpendymomaUnited States, Canada, United Kingdom
-
OSI PharmaceuticalsCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
NYU Langone HealthOSI PharmaceuticalsTerminated
-
ori snapiriNot yet recruiting
-
University of OklahomaOSI PharmaceuticalsTerminatedPolycythemia VeraUnited States
-
OSI PharmaceuticalsCompletedNon-small Cell Lung CancerUnited States, Hungary, Spain, Taiwan, Korea, Republic of, Italy, United Kingdom, Canada, Australia, Belgium, Germany, Austria, Poland, Romania, Argentina, France, Czech Republic, Greece, Russian Federation
-
OSI PharmaceuticalsCompleted
-
OSI PharmaceuticalsCompletedCarcinoma, Non-Small-Cell LungUnited States, United Kingdom
-
OSI PharmaceuticalsCompleted
-
Astellas Pharma IncOSI PharmaceuticalsCompletedSCLC | Carcinoma, Small CellUnited Kingdom, United States
-
Astellas Pharma IncOSI PharmaceuticalsCompletedOvarian NeoplasmsUnited Kingdom, United States
-
Astellas Pharma IncOSI PharmaceuticalsCompleted
-
Astellas Pharma IncOSI PharmaceuticalsCompleted
-
University of PittsburghOSI PharmaceuticalsCompletedHead and Neck Squamous Cell CarcinomaUnited States
-
OSI PharmaceuticalsCompletedAdvanced Pancreatic CancerUnited States
-
University of WashingtonOSI PharmaceuticalsCompletedProstate CancerUnited States
-
OSI PharmaceuticalsCompletedAdvanced Non Small Cell Lung Cancer | Failed Prior ChemotherapyUnited States
-
AKI Critical Care Research FoundationUnknownContinuous Renal Replacement TherapyUnited States
-
University of PittsburghOSI PharmaceuticalsWithdrawnSkin RashUnited States
-
Astellas Pharma IncOSI PharmaceuticalsCompletedNon-Small Cell Lung CancerUnited States
-
Astellas Pharma IncOSI PharmaceuticalsCompleted
-
Astellas Pharma IncOSI PharmaceuticalsCompletedChronic Lymphocytic LeukemiaUnited States
-
Astellas Pharma IncOSI PharmaceuticalsCompletedAdvanced Solid TumorsUnited States, United Kingdom